Thrivent Financial for Lutherans’s Editas Medicine EDIT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-61,111	Closed	-$71K	–	2458
2025 Q1	$71K	Hold	61,111	–	–	﹤0.01%	2349
2024 Q4	$77K	Sell	61,111 -24,670	-29%	-$62.9K	﹤0.01%	2541
2024 Q3	$292K	Hold	85,781	–	–	﹤0.01%	2399
2024 Q2	$400K	Buy	+85,781	New	+$484K	﹤0.01%	2300
2023 Q2	–	Sell	-10,719	Closed	-$78K	–	2479
2023 Q1	$78K	Hold	10,719	–	–	﹤0.01%	2423
2022 Q4	$95K	Hold	10,719	–	–	﹤0.01%	2385
2022 Q3	$131K	Sell	10,719 -139,211	-93%	-$2.17M	﹤0.01%	2367
2022 Q2	$1.77M	Buy	149,930 +105,207	+235%	+$1.41M	﹤0.01%	1300
2022 Q1	$851K	Hold	44,723	–	–	﹤0.01%	1919
2021 Q4	$1.19M	Buy	+44,723	New	+$1.54M	﹤0.01%	1746
2021 Q3	–	Sell	-34,208	Closed	-$1.94M	–	2477
2021 Q2	$1.94M	Hold	34,208	–	–	﹤0.01%	1443
2021 Q1	$1.44M	Sell	34,208 -4,322	-11%	-$246K	﹤0.01%	1632
2020 Q4	$2.7M	Hold	38,530	–	–	0.01%	1139
2020 Q3	$1.08M	Buy	+38,530	New	+$1.25M	﹤0.01%	1526
2017 Q2	–	Sell	-50,941	Closed	-$1.14M	–	2040
2017 Q1	$1.14M	Buy	+50,941	New	+$1.06M	﹤0.01%	1097

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Thrivent Financial for Lutherans's EDIT Position: Q2 2025 in Review

Thrivent Financial for Lutherans sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 61,111 shares — an estimated $71K sold.

Thrivent Financial for Lutherans first reported a position in EDIT in Q1 2017 and held it in 15 quarters. The position peaked at $2.7M in Q4 2020. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

Thrivent Financial for Lutherans reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
Thrivent Financial for Lutherans sold 61,111 Editas Medicine shares in Q2 2025, an estimated $71K.
Thrivent Financial for Lutherans first reported a position in Editas Medicine in Q1 2017 and held it in 15 quarters.
Thrivent Financial for Lutherans's Editas Medicine position peaked at $2.7M in Q4 2020.
193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2025, filed 11 Aug 2025.